RPL22 Antibody
Référence MBS8582384-0,1mL-FITC
Conditionnement : 0.1mL(FITC)
Marque : MyBiosource
RPL22 Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS8582384MBS8582384 is an antibody targeting RPL22. Also known as RPL22 Antibody. Reactive in Human, Mouse, Rat, Chicken, Monkey, Pig. Host: Rabbit. Rabbit polyclonal antibody to RPL22 More details
Product Overview
Online Datasheet in PDFProduct Name
RPL22, Polyclonal Antibody
Full Product Name
RPL22 Antibody
Product Gene Name
anti-RPL22 antibody
Product Synonym Names
60S ribosomal protein L22; EBER-associated protein; EAP; Epstein-Barr virus small RNA-associated protein; Heparin-binding protein HBp15
Clonality
Polyclonal
Isotype
IgG
Host
Rabbit
Species Reactivity
Human, Mouse, Rat, Chicken, Monkey, Pig
Form/Format
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH7.3, 30% glycerol, and 0.01% sodium azide.
Purity/Purification
The antibody was purified by immunogen affinity chromatography.
Specificity
Recognizes endogenous levels of RPL22 protein.
Preparation and Storage
Shipped at 4 degree C. Upon delivery aliquot and store at -20 degree C for one year. Avoid freeze/thaw cycles.
Molecular Weight
14,787 Da
Chromosome Location
Chromosome: 1; NC_000001.10 (6245080..6259679, complement). Location: 1p36.31
OMIM
180474
Immunogen
KLH-conjugated synthetic peptide encompassing a sequence within the center region of human RPL22. The exact sequence is proprietary.
Product Categories/Family for anti-RPL22 antibody
Primary Antibody
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for anti-RPL22 antibody
Western Blot (WB), Immunohistochemistry (IHC)
Application Notes for anti-RPL22 antibody
WB: 1:500-1:1000
IHC: 1:50-1:200
IHC: 1:50-1:200
Other Notes
Small volumes of anti-RPL22 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for RPL22. It may not necessarily be applicable to this product.
UniProt Primary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
60S ribosomal protein L22 proprotein
NCBI Official Synonym Full Names
ribosomal protein L22
NCBI Official Symbol
RPL22
NCBI Official Synonym Symbols
EAP; L22; HBP15; HBP15/L22
UniProt Protein Name
60S ribosomal protein L22
UniProt Synonym Protein Names
EBER-associated protein; EAP; Epstein-Barr virus small RNA-associated protein; Heparin-binding protein HBp15
Protein Family
50S ribosomal protein
UniProt Gene Name
RPL22
UniProt Synonym Gene Names
EAP
UniProt Entry Name
RL22_HUMAN
NCBI Protein Information
60S ribosomal protein L22; EBER-associated protein; heparin-binding protein 15; heparin-binding protein HBp15; Epstein-Barr-encoded RNA-associated protein; Epstein-Barr virus small RNA-associated protein
NCBI Summary for RPL22
Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a cytoplasmic ribosomal protein that is a component of the 60S subunit. The protein belongs to the L22E family of ribosomal proteins. Its initiating methionine residue is post-translationally removed. The protein can bind specifically to Epstein-Barr virus-encoded RNAs (EBERs) 1 and 2. The mouse protein has been shown to be capable of binding to heparin. Transcript variants utilizing alternative polyA signals exist. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. It was previously thought that this gene mapped to 3q26 and that it was fused to the acute myeloid leukemia 1 (AML1) gene located at 21q22 in some therapy-related myelodysplastic syndrome patients with 3;21 translocations; however, these fusions actually involve a ribosomal protein L22 pseudogene located at 3q26, and this gene actually maps to 1p36.3-p36.2. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for RPL22
RPL22: a cytoplasmic ribosomal protein that is a component of the 60S subunit. The protein belongs to the L22E family of ribosomal proteins. Its initiating methionine residue is post-translationally removed. The protein can bind specifically to Epstein-Barr virus-encoded RNAs (EBERs) 1 and 2. The mouse protein has been shown to be capable of binding to heparin. Transcript variants utilizing alternative polyA signals exist. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. It was previously thought that this gene mapped to 3q26 and that it was fused to the acute myeloid leukemia 1 (AML1) gene located at 21q22 in some therapy-related myelodysplastic syndrome patients with 3;21 translocations; however, these fusions actually involve a ribosomal protein L22 pseudogene located at 3q26, and this gene actually maps to 1p36.3-p36.2. [provided by RefSeq, Jul 2008]
Protein type: RNA-binding
Chromosomal Location of Human Ortholog: 1p36.31
Cellular Component: focal adhesion; cytoplasm; cytosol; nucleus; ribonucleoprotein complex
Molecular Function: heparin binding; protein binding; structural constituent of ribosome; RNA binding
Biological Process: SRP-dependent cotranslational protein targeting to membrane; translational elongation; cellular protein metabolic process; viral reproduction; translation; mRNA catabolic process, nonsense-mediated decay; translational initiation; alpha-beta T cell differentiation; gene expression; viral transcription; viral infectious cycle; translational termination
Show more Protein type: RNA-binding
Chromosomal Location of Human Ortholog: 1p36.31
Cellular Component: focal adhesion; cytoplasm; cytosol; nucleus; ribonucleoprotein complex
Molecular Function: heparin binding; protein binding; structural constituent of ribosome; RNA binding
Biological Process: SRP-dependent cotranslational protein targeting to membrane; translational elongation; cellular protein metabolic process; viral reproduction; translation; mRNA catabolic process, nonsense-mediated decay; translational initiation; alpha-beta T cell differentiation; gene expression; viral transcription; viral infectious cycle; translational termination
Research Articles on RPL22
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Pathways associated with anti-RPL22 antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Cap-dependent Translation Initiation Pathway antibodies | Cap-dependent Translation Initiation Pathway Diagram |
| Cytoplasmic Ribosomal Proteins Pathway antibodies | Cytoplasmic Ribosomal Proteins Pathway Diagram |
| Disease Pathway antibodies | Disease Pathway Diagram |
| Eukaryotic Translation Elongation Pathway antibodies | Eukaryotic Translation Elongation Pathway Diagram |
| Eukaryotic Translation Initiation Pathway antibodies | Eukaryotic Translation Initiation Pathway Diagram |
| Eukaryotic Translation Termination Pathway antibodies | Eukaryotic Translation Termination Pathway Diagram |
| Formation Of A Pool Of Free 40S Subunits Pathway antibodies | Formation Of A Pool Of Free 40S Subunits Pathway Diagram |
| GTP Hydrolysis And Joining Of The 60S Ribosomal Subunit Pathway antibodies | GTP Hydrolysis And Joining Of The 60S Ribosomal Subunit Pathway Diagram |
| Gene Expression Pathway antibodies | Gene Expression Pathway Diagram |
| Influenza Infection Pathway antibodies | Influenza Infection Pathway Diagram |
Diseases associated with anti-RPL22 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Neoplasms Antibodies | >120 publications with RPL22 and Neoplasms |
| Lymphoma Antibodies | >74 publications with RPL22 and Lymphoma |
| Neoplasms, Experimental Antibodies | >55 publications with RPL22 and Neoplasms, Experimental |
| Carcinoma Antibodies | >40 publications with RPL22 and Carcinoma |
| Adenocarcinoma Antibodies | >10 publications with RPL22 and Adenocarcinoma |
| Bone Diseases Antibodies | >7 publications with RPL22 and Bone Diseases |
| Necrosis Antibodies | >7 publications with RPL22 and Necrosis |
| Liver Diseases Antibodies | >5 publications with RPL22 and Liver Diseases |
| Liver Neoplasms Antibodies | >4 publications with RPL22 and Liver Neoplasms |
| Inflammation Antibodies | >3 publications with RPL22 and Inflammation |
Organs/Tissues associated with anti-RPL22 antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >45 publications with RPL22 and Blood |
| Lymph Node Antibodies | >16 publications with RPL22 and Lymph Node |
| Lymph Antibodies | >15 publications with RPL22 and Lymph |
| Liver Antibodies | >15 publications with RPL22 and Liver |
| Stomach Antibodies | >10 publications with RPL22 and Stomach |
| Brain Antibodies | >10 publications with RPL22 and Brain |
| Skin Antibodies | >6 publications with RPL22 and Skin |
| Spleen Antibodies | >5 publications with RPL22 and Spleen |
| Thymus Antibodies | >4 publications with RPL22 and Thymus |
| Lung Antibodies | >4 publications with RPL22 and Lung |


